Citations (99)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Sheng Liu, Guanyun Shi, Zhengbo Pan, Weisong Cheng, Linfei Xu, Xingzhang Lin, Yongfeng Lin, Liming Zhang, Guanghua Ji, Xin Lv & Dongguo Wang. (2023) Integrated Bioinformatics Analysis for the Identification of Key lncRNAs, mRNAs, and Potential Drugs in Clear Cell Renal Cell Carcinomas. International Journal of General Medicine 16, pages 2063-2080.
Read now
Read now
Rickinder Grewal, Hae Yoon G. Choung, Lisa L. Roberts, Timothy Beane, Luojing Chen, Daniel X. Gilroy, Phillip M. Rappold & Thu H. Le. (2022) TMEM27 expression and clinical characteristics and survival in clear cell renal cell carcinoma. Acta Oncologica 61:12, pages 1507-1511.
Read now
Read now
Francesco Massari & Veronica Mollica. (2022) Personalizing immunotherapy for renal cell carcinoma: how far have we come?. Expert Opinion on Biological Therapy 22:10, pages 1221-1225.
Read now
Read now
Bin Liu, Faping Li, Mingdi Liu, Zhixiang Xu, Baoshan Gao, Yishu Wang & Honglan Zhou. (2021) Prognostic Roles of Phosphofructokinase Platelet in Clear Cell Renal Cell Carcinoma and Correlation with Immune Infiltration. International Journal of General Medicine 14, pages 3645-3658.
Read now
Read now
Carlo Di Bona, Viktoria Stühler, Steffen Rausch, Arnulf Stenzl & Jens Bedke. (2021) Pembrolizumab for the treatment of renal cell carcinoma. Expert Opinion on Biological Therapy 21:9, pages 1157-1164.
Read now
Read now
Shun-Lai Li, Ting-Qi Jiang, Qing-Wei Cao & Shan-Mei Liu. (2021) Transmembrane protein ADAM29 facilitates cell proliferation, invasion and migration in clear cell renal cell carcinoma. Journal of Chemotherapy 33:1, pages 40-50.
Read now
Read now
Jie Wu, Yu-Chen Wang, Wen-Hao Xu, Wen-Jie Luo, Fang-Ning Wan, Hai-Liang Zhang, Ding-Wei Ye, Yuan-Yuan Qu & Yi-Ping Zhu. (2020) High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell Carcinoma. OncoTargets and Therapy 13, pages 10453-10464.
Read now
Read now
Zhenpeng Zhu, Chunru Xu, Lanruo Lin, Tongde Lv, Tianyu Cai & Jian Lin. (2020) Prognostic Value and Potential Biological Functions of CLDN8 in Patients with Clear Cell Renal Cell Carcinoma. OncoTargets and Therapy 13, pages 9135-9145.
Read now
Read now
Dong Lv, Ying Xiang, Qi Yang, Juncheng Yao & Qiang Dong. (2020) Long Non-Coding RNA TUG1 Promotes Cell Proliferation and Inhibits Cell Apoptosis, Autophagy in Clear Cell Renal Cell Carcinoma via MiR-31-5p/FLOT1 Axis. OncoTargets and Therapy 13, pages 5857-5868.
Read now
Read now
Francesca Raimondo & Marina Pitto. (2020) Prognostic significance of proteomics and multi-omics studies in renal carcinoma. Expert Review of Proteomics 17:4, pages 323-334.
Read now
Read now
Viktoria Stühler, Jan Moritz Maas, Steffen Rausch, Arnulf Stenzl & Jens Bedke. (2020) Immune checkpoint inhibition for the treatment of renal cell carcinoma. Expert Opinion on Biological Therapy 20:1, pages 83-94.
Read now
Read now
Articles from other publishers (88)
Guang Jia, Dan Lv & Shaobin Ni. (2023) Circ_0061140 Potentiates Clear Cell Renal Cell Carcinoma Progression Via the MicroRNA-126-5p/ADAM9 Axis. Molecular Biotechnology.
Crossref
Crossref
Lulu Zhang, Yulei Li, Bin Cai, Jiajun Chen, Keyuan Zhao, Mengyao Li, Juan Lang, Kaifang Wang, Shouhua Pan & Ke Zhu. (2023) A Notch signaling-related lncRNA signature for predicting prognosis and therapeutic response in clear cell renal cell carcinoma. Scientific Reports 13:1.
Crossref
Crossref
Lv Tian, Yiming Wang, Zhiyuan Zhang, Xuechao Feng, Fengjun Xiao & Minru Zong. (2023) CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma. European Journal of Medical Research 28:1.
Crossref
Crossref
Penglong Cao, Mingying Chen, Tianya Zhang, Qin Zheng & Mulin Liu. (2023) A sialyltransferases-related gene signature serves as a potential predictor of prognosis and therapeutic response for bladder cancer. European Journal of Medical Research 28:1.
Crossref
Crossref
Shuangze Zhong, Shangjin Chen, Hansheng Lin, Yuancheng Luo & Jingwei He. (2023) Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role. BMC Urology 23:1.
Crossref
Crossref
Hui-feng Wu, Hao Liu, Zhe-wei Zhang & Ji-min Chen. (2023) CENPE and LDHA were potential prognostic biomarkers of chromophobe renal cell carcinoma. European Journal of Medical Research 28:1.
Crossref
Crossref
Wencong Ding, Min Zhang, Ping Zhang, Xianghong Zhang, Junwei Sun & Biying Lin. (2023) Identification of anoikis-related subtypes and immune landscape in kidney renal clear cell carcinoma. Scientific Reports 13:1.
Crossref
Crossref
Jiayi Zeng, Ping Zhu, Yanlin Tang, Changzheng Zhang, Chujin Ye, Shouyu Cheng, Kaiwen Tian, Bowen Yang, Weinan Zeng, Yanjun Liu, Zhiyong Xian & Yuming Yu. (2023) Identification of pyroptosis-related subtypes and comprehensive analysis of characteristics of the tumor microenvironment infiltration in clear cell renal cell carcinoma. Scientific Reports 13:1.
Crossref
Crossref
Huajie Mao, Runzhi Wang, Fengling Shao, Ming Zhao, Dayu Tian, Hua Xia & Ya Zhao. (2023) HMGCS2 serves as a potential biomarker for inhibition of renal clear cell carcinoma growth. Scientific Reports 13:1.
Crossref
Crossref
QingZhi Xie, FuQiang Qin, LiHui Luo, ShaoQuan Deng, Ke Zeng, YunChou Wu, DunMing Liao, Lin Luo & KangNing Wang. (2023) hsa_circ_0003596, as a novel oncogene, regulates the malignant behavior of renal cell carcinoma by modulating glycolysis. European Journal of Medical Research 28:1.
Crossref
Crossref
Pan-Pan Jia, Rohana Chandrajith, Muhammad Junaid, Tian-Yun Li, Yong-Zhi Li, Xing-Yi Wei, Li Liu & De-Sheng Pei. (2023) Elucidating environmental factors and their combined effects on CKDu in Sri Lanka using zebrafish. Environmental Pollution 332, pages 121967.
Crossref
Crossref
Francesco Lasorsa, Monica Rutigliano, Martina Milella, Matteo Ferro, Savio Domenico Pandolfo, Felice Crocetto, Riccardo Autorino, Michele Battaglia, Pasquale Ditonno & Giuseppe Lucarelli. (2023) Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers. International Journal of Molecular Sciences 24:17, pages 13179.
Crossref
Crossref
Maoshu Zhu, Yongsheng Li, Yun Wang, Pingli Lin, Jun Mi & Weimin Zhong. (2023) Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma. European Journal of Medical Research 28:1.
Crossref
Crossref
Francesco Lasorsa, Monica Rutigliano, Martina Milella, Matteo Ferro, Savio Domenico Pandolfo, Felice Crocetto, Octavian Sabin Tataru, Riccardo Autorino, Michele Battaglia, Pasquale Ditonno & Giuseppe Lucarelli. (2023) Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma. Journal of Clinical Medicine 12:12, pages 3888.
Crossref
Crossref
Mingyue Tan, Qi Pan, Qi Wu, Jianfa Li & Jun Wang. (2023) Aldolase B attenuates clear cell renal cell carcinoma progression by inhibiting CtBP2. Frontiers of Medicine 17:3, pages 503-517.
Crossref
Crossref
Dzenis Koca, Irinka Séraudie, Rémy Jardillier, Claude Cochet, Odile Filhol & Laurent Guyon. (2023) COL7A1 Expression Improves Prognosis Prediction for Patients with Clear Cell Renal Cell Carcinoma Atop of Stage. Cancers 15:10, pages 2701.
Crossref
Crossref
Francesco Lasorsa, Nicola Antonio di Meo, Monica Rutigliano, Martina Milella, Matteo Ferro, Savio Domenico Pandolfo, Felice Crocetto, Octavian Sabin Tataru, Riccardo Autorino, Michele Battaglia, Pasquale Ditonno & Giuseppe Lucarelli. (2023) Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice. Biomedicines 11:4, pages 1071.
Crossref
Crossref
Marta Correia de Sousa, Etienne Delangre, Miranda Türkal, Michelangelo Foti & Monika Gjorgjieva. (2023) Endoplasmic Reticulum Stress in Renal Cell Carcinoma. International Journal of Molecular Sciences 24:5, pages 4914.
Crossref
Crossref
Giuseppe Lucarelli, Giuseppe Stefano Netti, Monica Rutigliano, Francesco Lasorsa, Davide Loizzo, Martina Milella, Annalisa Schirinzi, Antonietta Fontana, Francesca Di Serio, Roberto Tamma, Domenico Ribatti, Michele Battaglia, Elena Ranieri & Pasquale Ditonno. (2023) MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation. International Journal of Molecular Sciences 24:5, pages 4814.
Crossref
Crossref
Chien-Liang Liu, Hung-Wen Tsai, Shu-Ling Peng, Ching-Ping Chang, Yu-Hao Chang & Huei-Sheng Huang. (2023) CDCP1 (CUB domain containing protein 1) is a potential urine-based biomarker in the diagnosis of low-grade urothelial carcinoma. PLOS ONE 18:3, pages e0281873.
Crossref
Crossref
Matteo Ferro, Gennaro Musi, Michele Marchioni, Martina Maggi, Alessandro Veccia, Francesco Del Giudice, Biagio Barone, Felice Crocetto, Francesco Lasorsa, Alessandro Antonelli, Luigi Schips, Riccardo Autorino, Gian Maria Busetto, Daniela Terracciano, Giuseppe Lucarelli & Octavian Sabin Tataru. (2023) Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects. International Journal of Molecular Sciences 24:5, pages 4615.
Crossref
Crossref
Bisera Stepanovska Tanturovska, Roxana Manaila, Doriano Fabbro & Andrea Huwiler. (2023) Lipids as Targets for Renal Cell Carcinoma Therapy. International Journal of Molecular Sciences 24:4, pages 3272.
Crossref
Crossref
Youcef M. Rustum, Ryan Reis & Tara M. Rustum. (2023) Druggable Biomarkers Altered in Clear Cell Renal Cell Carcinoma: Strategy for the Development of Mechanism-Based Combination Therapy. International Journal of Molecular Sciences 24:2, pages 902.
Crossref
Crossref
Jiangyong Lou, Xiaoming Liu, Xiaodong Fan, Xiaoming Xu, Zhichao Wang & Liqun Wang. (2023) Lncrna FEZf1-as1 negatively regulates ETNK1 to promote malignant progression of renal cell carcinoma. Journal of Medical Biochemistry 42:2, pages 232-238.
Crossref
Crossref
Dmitry L. Maslov, Oxana P. Trifonova, Steven Lichtenberg, Elena E. Balashova, Zaman Z. Mamedli, Aleksandr A. Alferov, Ivan S. Stilidi, Petr G. Lokhov, Nikolay E. Kushlinskii & Alexander I. Archakov. (2022) Blood Plasma Metabolome Profiling at Different Stages of Renal Cell Carcinoma. Cancers 15:1, pages 140.
Crossref
Crossref
Juan WuYa-fei RenJun XieDong-sheng Li. (2022) Targeting CTLA-4 in Cancer: Biological Insights with a Focus on Renal Cell Carcinoma. annals of urologic oncology.
Crossref
Crossref
Kathleen M. McClain, Joshua N. Sampson, Jessica L. Petrick, Kaitlyn M. Mazzilli, Robert E. Gerszten, Clary B. Clish, Mark P. Purdue, Loren Lipworth & Steven C. Moore. (2022) Metabolomic Analysis of Renal Cell Carcinoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Metabolites 12:12, pages 1189.
Crossref
Crossref
Nicola Antonio di Meo, Francesco Lasorsa, Monica Rutigliano, Davide Loizzo, Matteo Ferro, Alessandro Stella, Cinzia Bizzoca, Leonardo Vincenti, Savio Domenico Pandolfo, Riccardo Autorino, Felice Crocetto, Emanuele Montanari, Marco Spilotros, Michele Battaglia, Pasquale Ditonno & Giuseppe Lucarelli. (2022) Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets. International Journal of Molecular Sciences 23:22, pages 14360.
Crossref
Crossref
Dorin Novacescu, Bogdan Ovidiu Feciche, Alin Adrian Cumpanas, Razvan Bardan, Andrei Valentin Rusmir, Yahya Almansour Bitar, Vlad Ilie Barbos, Talida Georgiana Cut, Marius Raica & Silviu Constantin Latcu. (2022) Contemporary Clinical Definitions, Differential Diagnosis, and Novel Predictive Tools for Renal Cell Carcinoma. Biomedicines 10:11, pages 2926.
Crossref
Crossref
Giuseppe Lucarelli, Monica Rutigliano, Davide Loizzo, Nicola Antonio di Meo, Francesco Lasorsa, Mauro Mastropasqua, Eugenio Maiorano, Cinzia Bizzoca, Leonardo Vincenti, Michele Battaglia & Pasquale Ditonno. (2022) MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome. International Journal of Molecular Sciences 23:22, pages 13968.
Crossref
Crossref
Qian Zhang, Lei Ding, Tianren Zhou, Qidi Zhai, Chenbo Ni, Chao Liang & Jie Li. (2022) A metabolic reprogramming-related prognostic risk model for clear cell renal cell carcinoma: From construction to preliminary application. Frontiers in Oncology 12.
Crossref
Crossref
Zhi-Guo Liu, Jing Su, Hao Liu, Xue-Jian Yang, Xue Yang, Ye Wei, Xin-Yao Zhu, Yong Song, Xian-Cheng Zhao & Hong-Lin Guo. (2022) Comprehensive bioinformatics analysis of the E2F family in human clear cell renal cell carcinoma. Oncology Letters 24:4.
Crossref
Crossref
Sung Ryul Shim, Sun Il Kim, Se Joong Kim & Dae Sung Cho. (2022) Prognostic nutritional index as a prognostic factor for renal cell carcinoma: A systematic review and meta-analysis. PLOS ONE 17:8, pages e0271821.
Crossref
Crossref
Antonios Koudonas, Maria Papaioannou, Spyridon Kampantais, Anastasios Anastasiadis, Konstantinos HatzimouratidisGeorgios Dimitriadis. (2022) Methylation of PCDH17 and NEFH as prognostic biomarker for nonmetastatic RCC: A cohort study. Medicine 101:28, pages e29599.
Crossref
Crossref
Yifu Liu, Shengqiang Fu, Zhicheng Zhang, Siyuan Wang, Xiaofeng Cheng, Zhilong Li, Yi Ding, Ting Sun & Ming Ma. (2022) GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment. Disease Markers 2022, pages 1-25.
Crossref
Crossref
Fangfang Hu, Yan Ren, Zunyun Wang, Hui Zhou, Yumei Luo, Minghua Wang, Faqing Tian, Jian Zheng, Juan Du & Gang Pang. (2022) Bioinformatics analysis of KLF2 as a potential prognostic factor in ccRCC and association with epithelial‑mesenchymal transition. Experimental and Therapeutic Medicine 24:3.
Crossref
Crossref
Menggang Zhang, Xiao Yu, Qiyao Zhang, Zongzong Sun, Yuting He & Wenzhi Guo. (2022) MIR4435-2HG: A newly proposed lncRNA in human cancer. Biomedicine & Pharmacotherapy 150, pages 112971.
Crossref
Crossref
Xingyuan Wang, Dechao Li, Zhinan Xia, Lichen Teng, Yongsheng Chen, Jie Meng & Changfu Li. (2022) Zinc oxide nanoparticles promotes ferroptosis to repress cancer cell survival and inhibits invasion and migration by targeting miR-27a-3p/YAP axis in renal cell carcinoma. Arabian Journal of Chemistry 15:6, pages 103753.
Crossref
Crossref
Wallax Augusto Silva Ferreira & Edivaldo Herculano Correa de Oliveira. (2022) Expression of GOT2 Is Epigenetically Regulated by DNA Methylation and Correlates with Immune Infiltrates in Clear-Cell Renal Cell Carcinoma. Current Issues in Molecular Biology 44:6, pages 2472-2489.
Crossref
Crossref
Xiaming Pei, Xiaoxiao Hu, Zhenzhou Xu, Kan Liu, Shusuan Jiang, Zhizhong Liu, Yu Xie & Weiqing Han. (2022) Clinical Effect of Retroperitoneal Laparoscopic Radical Nephrectomy on Renal Cell Carcinoma, the Influence of Renal Function, and the Influencing Factors of Recurrence. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-8.
Crossref
Crossref
Huibing Li, Pengyi Zheng, Zhijun Li, Qingjiang Han, Bisheng Zhou, Xiaohui Wang & Kaixuan Wang. (2022) NCAPG Promotes the Proliferation of Renal Clear Cell Carcinoma via Mediating with CDK1. Disease Markers 2022, pages 1-12.
Crossref
Crossref
Nicola Antonio di Meo, Davide Loizzo, Savio Domenico Pandolfo, Riccardo Autorino, Matteo Ferro, Camillo Porta, Alessandro Stella, Cinzia Bizzoca, Leonardo Vincenti, Felice Crocetto, Octavian Sabin Tataru, Monica Rutigliano, Michele Battaglia, Pasquale Ditonno & Giuseppe Lucarelli. (2022) Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer. International Journal of Molecular Sciences 23:8, pages 4173.
Crossref
Crossref
Xudong Zhou & Tingting Cao. (2022) Zinc Oxide Nanoparticle Inhibits Tumorigenesis of Renal Cell Carcinoma by Modulating Lipid Metabolism Targeting miR-454-3p to Repressing Metabolism Enzyme ACSL4. Journal of Oncology 2022, pages 1-10.
Crossref
Crossref
Qingping Peng, Ling Liu, Ting Li, Changjiang Lei & Huan Wan. (2022) Prognostic impact of prognostic nutritional index on renal cell carcinoma: A meta-analysis of 7,629 patients. PLOS ONE 17:3, pages e0265119.
Crossref
Crossref
Hui Yang, Hongbo Zhao, Zhongkun Ren, Xiaojia Yi, Qiao Zhang, Zhe Yang, Yingmin Kuang & Yuechun Zhu. (2021) Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC. Acta Biochimica et Biophysica Sinica 54:2, pages 220-231.
Crossref
Crossref
Matteo Ferro, Daniela Terracciano, Gennaro Musi, Ottavio de Cobelli, Mihai Dorin Vartolomei, Rocco Damiano, Francesco Cantiello, Carlo Buonerba, Michele Morelli, Francesco Alessandro Mistretta, Stefano Luzzago, Sisto Perdonà, Paola Del Prete, Francesco Del Giudice, Gian Maria Busetto, Angelo Porreca, Riccardo Autorino, Matteo Manfredi, Francesco Porpiglia, Matteo Muto, Davide Loizzo, Pasquale Ditonno, Michele Battaglia & Giuseppe Lucarelli. (2022) Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies. Urologia Internationalis 106:1, pages 75-82.
Crossref
Crossref
Yan Deng, Feng Zhang, Zhen-Gang Sun & Shuai Wang. (2021) Development and Validation of a Prognostic Signature Associated With Tumor Microenvironment Based on Autophagy-Related lncRNA Analysis in Hepatocellular Carcinoma. Frontiers in Medicine 8.
Crossref
Crossref
Wen Li, Xiaobin Wang, Xianbin Zhang, Peng Gong, Degang Ding, Ning Wang & Zhifeng Wang. (2021) Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics. Lipids in Health and Disease 20:1.
Crossref
Crossref
Tao Shen, Wangxiao Xia, Sainan Min, Zixuan Yang, Lehua Cheng, Wei Wang, Qianxi Zhan, Fanghong Shao, Xuehan Zhang, Zhiyu Wang, Yan Zhang, Guodong Shen, Huafeng Zhang, Li-Ling Wu, Guang-Yan Yu, Qing-Peng Kong & Xiangting Wang. (2021) A pair of long intergenic non-coding RNA LINC00887 variants act antagonistically to control Carbonic Anhydrase IX transcription upon hypoxia in tongue squamous carcinoma progression. BMC Biology 19:1.
Crossref
Crossref
Ernesto Rossi, Melissa Bersanelli, Alain Jonathan Gelibter, Nicolò Borsellino, Claudia Caserta, Laura Doni, Marco Maruzzo, Alessandra Mosca, Carmela Pisano, Elena Verzoni & Paolo Andrea Zucali. (2021) Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?. Current Oncology Reports 23:12.
Crossref
Crossref
Jonathan Anker, Justin Miller, Nicole Taylor, Natasha Kyprianou & Che-Kai Tsao. (2021) From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma. Cells 10:11, pages 3231.
Crossref
Crossref
Xin Lu, Peng Dou, Xiaoyu Xie, Xiaolin Wang, Xinyu Liu, Rui Hua & Guowang Xu. (2021) Development of a novel analytical method for inflammation and immunity-related metabolites in serum based on liquid chromatography tandem mass spectrometry. Talanta 234, pages 122631.
Crossref
Crossref
Naimeng Liu, Xinhui Wang, Hao Wu, Xiaye Lv, Haoqun Xie, Zhen Guo, Jing Wang, Gaojing Dou, Chenxi Zhang & Mindan Sun. (2021) Computational study of effective matrix metalloproteinase 9 (MMP9) targeting natural inhibitors. Aging 13:19, pages 22867-22882.
Crossref
Crossref
Yusa Chen, Yumei Liang, Ying Chen, Shaxi Ouyang, Kanghan Liu & Wei Yin. (2021) Identification of Prognostic Metabolism-Related Genes in Clear Cell Renal Cell Carcinoma. Journal of Oncology 2021, pages 1-13.
Crossref
Crossref
Florence Guida, Vanessa Y. Tan, Laura J. Corbin, Karl Smith-Byrne, Karine Alcala, Claudia Langenberg, Isobel D. Stewart, Adam S. Butterworth, Praveen Surendran, David Achaintre, Jerzy Adamski, Pilar Amiano, Manuela M. Bergmann, Caroline J. Bull, Christina C. Dahm, Audrey Gicquiau, Graham G. Giles, Marc J. Gunter, Toomas Haller, Arnulf Langhammer, Tricia L. Larose, Börje Ljungberg, Andres Metspalu, Roger L. Milne, David C. Muller, Therese H. Nøst, Elin Pettersen Sørgjerd, Cornelia Prehn, Elio Riboli, Sabina Rinaldi, Joseph A. Rothwell, Augustin Scalbert, Julie A. Schmidt, Gianluca Severi, Sabina Sieri, Roel Vermeulen, Emma E. Vincent, Melanie Waldenberger, Nicholas J. Timpson & Mattias Johansson. (2021) The blood metabolome of incident kidney cancer: A case–control study nested within the MetKid consortium. PLOS Medicine 18:9, pages e1003786.
Crossref
Crossref
Xiaochen Qi, Quanlin Li, Xiangyu Che, Qifei Wang & Guangzhen Wu. (2021) The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC. Frontiers in Oncology 11.
Crossref
Crossref
Maria Rosaria Muroni, Silvia Ribback, Giovanni Sotgiu, Nils Kroeger, Laura Saderi, Andrea Angius, Paolo Cossu-Rocca & Maria Rosaria De Miglio. (2021) Prognostic Impact of Membranous/Nuclear Epidermal Growth Factor Receptor Localization in Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences 22:16, pages 8747.
Crossref
Crossref
Simone O. Heyliger, Karam F. A. Soliman, Marilyn D. Saulsbury & Romonia Renee Reams. (2021) The Identification of Zinc-Finger Protein 433 as a Possible Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma. Biomolecules 11:8, pages 1193.
Crossref
Crossref
Hye-Won Lee. (2021) Multidiscipline Immunotherapy-Based Rational Combinations for Robust and Durable Efficacy in Brain Metastases from Renal Cell Carcinoma. International Journal of Molecular Sciences 22:12, pages 6290.
Crossref
Crossref
Davide Loizzo, Nicola Antonio di Meo, Mattia Rocco Peluso, Monica Rutigliano, Matteo Matera, Carlos Miacola, Gaetano Palella, Michele Tedeschi, Marco Spilotros, Matteo Ferro, Octavian Sabin Tătaru, Mihai Dorin Vartolomei, Leonardo Vincenti, Pasquale Ditonno, Michele Battaglia & Giuseppe Lucarelli. (2021) Novel Insights into the Molecular Mechanisms of Ischemia/Reperfusion Injury in Kidney Transplantation. Transplantology 2:2, pages 191-207.
Crossref
Crossref
Yingli Sui, Kun Lu & Lin Fu. (2021) Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis. PeerJ 9, pages e11272.
Crossref
Crossref
Liang Meng, Deqiang Chen, Gaopei Meng, Li Lu & Chenggang Han. (2021) Dysregulation of the Sirt5/IDH2 axis contributes to sunitinib resistance in human renal cancer cells. FEBS Open Bio 11:3, pages 921-931.
Crossref
Crossref
Dario Garcia-Rojo, Angel Prera, Jesus Muñoz-Rodriguez, Joan Carles OlivaArturo Dominguez & Joan Prats. (2021) Prognostic value of lymphocyte-to-monocyte ratio previously determined to surgery in patients with non-metastatic renal cell carcinoma. Medicine 100:3, pages e24152.
Crossref
Crossref
Vincenzo Losappio, Barbara Infante, Serena Leo, Dario Troise, Martina Calvaruso, Piercarla Vitale, Stefania Renzi, Giovanni Stallone & Giuseppe Castellano. (2021) Nutrition-Based Management of Inflammaging in CKD and Renal Replacement Therapies. Nutrients 13:1, pages 267.
Crossref
Crossref
Benjiang Qian, Xiaoyan Ying, Guang Yang, Huizhang Li & Jianming Tan. (2021) TRIP13 is identified as a prognosis biomarker for renal clear cell carcinoma and promotes renal cell carcinoma cell proliferation, migration and invasion. BIOCELL 45:3, pages 577-588.
Crossref
Crossref
Baozhong Yu, Jiandong Zhang, Zejia Sun, Peng Cao, Xiang Zheng, Zihao Gao, Haoyuan Cao, Feilong Zhang & Wei Wang. (2021) Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis. Medicine 100:1, pages e24257.
Crossref
Crossref
Giuseppe Lucarelli, Matteo Ferro, Davide Loizzo, Cristina Bianchi, Daniela Terracciano, Francesco Cantiello, Lauren N. Bell, Stefano Battaglia, Camillo Porta, Angela Gernone, Roberto A. Perego, Eugenio Maiorano, Ottavio de Cobelli, Giuseppe Castellano, Leonardo Vincenti, Pasquale Ditonno & Michele Battaglia. (2020) Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma. Metabolites 10:12, pages 509.
Crossref
Crossref
Chao-Liang Xu, Lei Chen, Deng Li, Fei-Teng Chen, Ming-Lei Sha & Yi Shao. (2020) Acyl-CoA Thioesterase 8 and 11 as Novel Biomarkers for Clear Cell Renal Cell Carcinoma. Frontiers in Genetics 11.
Crossref
Crossref
Mei Liu, Qiufeng Pan, Ruihai Xiao, Yi Yu, Wenbao Lu & Longwang Wang. (2020) A cluster of metabolism-related genes predict prognosis and progression of clear cell renal cell carcinoma. Scientific Reports 10:1.
Crossref
Crossref
Caipeng Qin, Huaqi Yin, Huixin Liu, Feng Liu, Yiqing Du & Tao Xu. (2020) The Significance of Fibrosis Quantification as a Marker in Assessing Pseudo-Capsule Status and Clear Cell Renal Cell Carcinoma Prognosis. Diagnostics 10:11, pages 895.
Crossref
Crossref
Yiqiao Zhao, Zijia Tao & Xiaonan Chen. (2020) A Three-Metabolic-Genes Risk Score Model Predicts Overall Survival in Clear Cell Renal Cell Carcinoma Patients. Frontiers in Oncology 10.
Crossref
Crossref
Johannes Uhlig, Andreas Leha, Laura M. Delonge, Anna-Maria Haack, Brian Shuch, Hyun S. Kim, Felix Bremmer, Lutz Trojan, Joachim Lotz & Annemarie Uhlig. (2020) Radiomic Features and Machine Learning for the Discrimination of Renal Tumor Histological Subtypes: A Pragmatic Study Using Clinical-Routine Computed Tomography. Cancers 12:10, pages 3010.
Crossref
Crossref
Vladimir Tolstikov, A. James Moser, Rangaprasad Sarangarajan, Niven R. Narain & Michael A. Kiebish. (2020) Current Status of Metabolomic Biomarker Discovery: Impact of Study Design and Demographic Characteristics. Metabolites 10:6, pages 224.
Crossref
Crossref
Yun Luo, Ningbo Geng, Baoqin Zhang, Jiping Chen & Haijun Zhang. (2020) Effects of harvesting and extraction methods on metabolite recovery from adherently growing mammalian cells. Analytical Methods 12:19, pages 2491-2498.
Crossref
Crossref
Giuseppe Stefano Netti, Giuseppe Lucarelli, Federica Spadaccino, Giuseppe Castellano, Margherita Gigante, Chiara Divella, Maria Teresa Rocchetti, Federica Rascio, Vito Mancini, Giovanni Stallone, Giuseppe Carrieri, Loreto Gesualdo, Michele Battaglia & Elena Ranieri. (2020) PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma. Aging 12:8, pages 7585-7602.
Crossref
Crossref
Johannes Uhlig, Lorenz Biggemann, Manuel M. Nietert, Tim Beißbarth, Joachim Lotz, Hyun S. Kim, Lutz TrojanAnnemarie Uhlig. (2020) Discriminating malignant and benign clinical T1 renal masses on computed tomography. Medicine 99:16, pages e19725.
Crossref
Crossref
Vincenzo Petrozza, Manuela Costantini, Claudia Tito, Laura Maria Giammusso, Veronica Sorrentino, Jessica Cacciotti, Natale Porta, Alessia Iaiza, Antonio Luigi Pastore, Angelina Di Carlo, Giuseppe Simone, Antonio Carbone, Michele Gallucci & Francesco Fazi. (2020) Emerging role of secreted miR-210-3p as potential biomarker for clear cell Renal Cell Carcinoma metastasis. Cancer Biomarkers 27:2, pages 181-188.
Crossref
Crossref
Tianbo Xu, Hailong Ruan, Su Gao, Jingchong Liu, Yuenan Liu, Zhengshuai Song, Qi Cao, Keshan Wang, Lin Bao, Di Liu, Junwei Tong, Jian Shi, Huageng Liang, Hongmei Yang, Ke Chen & Xiaoping Zhang. (2020) ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma. Aging 12:2, pages 1808-1827.
Crossref
Crossref
Weiqiang Xu, Xu Jiang, Chao Guan & Mingli Gu. (2020) The prognostic and predictive value of tumor infiltrating Macrophage and Neutrophil in patient with clear cell renal cell carcinoma: Tumor infiltrating lymphocytes in renal cell carcinoma. Medicine 99:46, pages e23181.
Crossref
Crossref
Hongyu Jin, Xiao He, Hui Zhou, Man Zhang, Qingqing Tang, Lede Lin, Jianqi Hao & Rui Zeng. (2020) Efficacy of raman spectroscopy in the diagnosis of kidney cancer. Medicine 99:27, pages e20933.
Crossref
Crossref
Liyuan Ge, Yimeng Song, Feilong Yang, Guojiang Zhao, Min Lu, Shudong Zhang & Lulin Ma. (2020) Clinical significance of circulating tumor cells detection in renal cell carcinoma with thrombus. Medicine 99:22, pages e20615.
Crossref
Crossref
Haosen Yang, Keqiang Yin, Yusheng Wang, Mancheng Xia, Ruiqin Zhang, Wenzhan Wang, Jiawei Chen, Chaoqi Wang & Weibing Shuang. (2019) Pre‐existing type 2 diabetes is an adverse prognostic factor in patients with renal cell carcinoma. Journal of Diabetes 11:12, pages 993-1001.
Crossref
Crossref
Jing Song, Fangzhou Song, Kun Liu, Wanfeng Zhang, Ruihan Luo, Yongyao Tang & Longke Ran. (2019) Multi-omics analysis reveals epithelial-mesenchymal transition-related gene FOXM1 as a novel prognostic biomarker in clear cell renal carcinoma. Aging 11:22, pages 10316-10337.
Crossref
Crossref
Gong Cheng, Di Liu, Huageng Liang, Hongmei Yang, Ke Chen & Xiaoping Zhang. (2019) A cluster of long non-coding RNAs exhibit diagnostic and prognostic values in renal cell carcinoma. Aging 11:21, pages 9597-9615.
Crossref
Crossref
Bangbei Wan, Bo Liu, Gang Yu, Yuan Huang & Cai Lv. (2019) Differentially expressed autophagy-related genes are potential prognostic and diagnostic biomarkers in clear-cell renal cell carcinoma. Aging 11:20, pages 9025-9042.
Crossref
Crossref
Yan Wang, Zhan Li, Wei Li, Le Zhou & Yuehua Jiang. (2019) Prognostic significance of long non-coding RNAs in clear cell renal cell carcinoma. Medicine 98:40, pages e17276.
Crossref
Crossref
Ji-Myung Kim, Min-Kyung Yeo, Jae Lim, In-Sang Song, Kwangsik Chun & Kyung-Hee Kim. (2019) APEX1 Expression as a Potential Diagnostic Biomarker of Clear Cell Renal Cell Carcinoma and Hepatobiliary Carcinomas. Journal of Clinical Medicine 8:8, pages 1151.
Crossref
Crossref
Jun Deng, Lei Li, Haimei Xia, Ju Guo, Xin Wu, Xiaorong Yang, Yanyan HongQingke Chen & Jieping Hu. (2019) A comparison of the prognosis of papillary and clear cell renal cell carcinoma. Medicine 98:27, pages e16309.
Crossref
Crossref